AERI insider transactions
Aerie Pharmaceuticals Inc. (AERI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AERI
- SEC Form 4: Mchugh Julie returned $245,449 worth of shares to the company (16,095 units at $15.25), closing all direct ownership in the company to cover taxes4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcgraw Benjamin F Iii returned $640,256 worth of shares to the company (41,984 units at $15.25), closing all direct ownership in the company to satisfy tax liability4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcdonnell Peter J returned $121,924 worth of shares to the company (7,995 units at $15.25), closing all direct ownership in the company (for withholding tax)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Kopczynski Casey C. returned $4,273,721 worth of shares to the company (280,244 units at $15.25), closing all direct ownership in the company (withholding tax)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Lang Peter Frederick returned $706,029 worth of shares to the company (46,297 units at $15.25), closing all direct ownership in the company (for withholding tax)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Larocca John returned $817,171 worth of shares to the company (53,585 units at $15.25), closing all direct ownership in the company to satisfy tax liability4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Gryska David W returned $205,738 worth of shares to the company (13,491 units at $15.25), closing all direct ownership in the company (tax liability)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Du Toit Michael returned $245,449 worth of shares to the company (16,095 units at $15.25), closing all direct ownership in the company to cover taxes4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Croarkin Richard returned $245,449 worth of shares to the company (16,095 units at $15.25), closing all direct ownership in the company (for withholding tax)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Calabrese Jeffrey returned $283,421 worth of shares to the company (18,585 units at $15.25), closing all direct ownership in the company (tax withholding)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Kannan Raj returned $3,290,691 worth of shares to the company (215,783 units at $15.25), closing all direct ownership in the company to cover taxes4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Calabrese Jeffrey covered exercise/tax liability with 179 shares, decreasing direct ownership by 0.95% to 18,585 units to satisfy tax liability4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Larocca John covered exercise/tax liability with 771 shares, decreasing direct ownership by 1% to 53,585 units to satisfy withholding obligation4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Calabrese Jeffrey covered exercise/tax liability with 265 shares, decreasing direct ownership by 1% to 18,764 units (withholding obligation)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Calabrese Jeffrey covered exercise/tax liability with 266 shares, decreasing direct ownership by 1% to 19,029 units (tax liability)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Calabrese Jeffrey was granted 11,276 shares, increasing direct ownership by 141% to 19,295 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mchugh Julie was granted 6,245 shares, increasing direct ownership by 63% to 16,095 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcgraw Benjamin F Iii was granted 6,245 shares, increasing direct ownership by 17% to 41,984 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcdonnell Peter J was granted 6,245 shares, increasing direct ownership by 357% to 7,995 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Gryska David W was granted 6,245 shares, increasing direct ownership by 119% to 11,495 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Du Toit Michael was granted 6,245 shares, increasing direct ownership by 63% to 16,095 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Croarkin Richard was granted 6,245 shares, increasing direct ownership by 63% to 16,095 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Kopczynski Casey C. was granted 19,015 shares, increasing direct ownership by 7% to 280,244 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Larocca John was granted 19,015 shares, increasing direct ownership by 54% to 54,356 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4 filed by Kannan Raj4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Lang Peter Frederick was granted 46,297 shares4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 3 filed by new insider Lang Peter Frederick3 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcgraw Benjamin F Iii covered exercise/tax liability with 10,324 shares, decreasing direct ownership by 22% to 35,739 units to satisfy withholding tax4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Larocca John covered exercise/tax liability with 1,973 shares, decreasing direct ownership by 5% to 35,341 units to satisfy withholding obligation4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Kopczynski Casey C. covered exercise/tax liability with 1,401 shares, decreasing direct ownership by 0.53% to 261,229 units to cover withholding tax4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Larocca John covered exercise/tax liability with 768 shares, decreasing direct ownership by 2% to 37,314 units to satisfy withholding obligation4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mitro Thomas A covered exercise/tax liability with 2,421 shares, decreasing direct ownership by 3% to 81,418 units (tax withholding)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Hollander David covered exercise/tax liability with 927 shares, decreasing direct ownership by 3% to 30,749 units (withholding obligation)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Kopczynski Casey C. covered exercise/tax liability with 1,839 shares, decreasing direct ownership by 0.70% to 262,630 units to satisfy tax liability4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Larocca John covered exercise/tax liability with 1,590 shares, decreasing direct ownership by 4% to 38,082 units (for tax liability)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mitro Thomas A covered exercise/tax liability with 2,870 shares, decreasing direct ownership by 3% to 83,839 units to satisfy withholding obligation4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcginley Kathleen covered exercise/tax liability with 878 shares, decreasing direct ownership by 4% to 23,993 units (withholding tax)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Kannan Raj was granted 215,783 shares4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 3 filed by new insider Kannan Raj3 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Hollander David covered exercise/tax liability with 2,162 shares, decreasing direct ownership by 6% to 31,676 units to cover taxes4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 3: New insider Calabrese Jeffrey claimed ownership of 8,019 shares3 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 3: New insider Mcginley Kathleen claimed ownership of 24,871 shares3 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Mcgraw Benjamin F Iii was granted 34,513 units of Common Stock, increasing direct ownership by 299% to 46,063 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Staten Christopher covered exercise/tax liability with 877 units of Common Stock, decreasing direct ownership by 4% to 21,710 units (for tax liability)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: LaRocca John covered exercise/tax liability with 765 units of Common Stock, decreasing direct ownership by 2% to 39,672 units (for withholding tax)4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 3: Staten Christopher claimed ownership of 22,587 units of Common Stock3 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: GRYSKA DAVID W was granted 1,750 units of Common Stock, increasing direct ownership by 50% to 5,250 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: MCGRAW BENJAMIN F III was granted 1,750 units of Common Stock, increasing direct ownership by 18% to 11,550 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: McHugh Julie was granted 1,750 units of Common Stock, increasing direct ownership by 22% to 9,850 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: du Toit Michael was granted 1,750 units of Common Stock, increasing direct ownership by 22% to 9,850 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Cagle Gerald D. was granted 1,750 units of Common Stock, increasing direct ownership by 10% to 20,050 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: McDonnell Peter J was granted 1,750 units of Common Stock4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Croarkin Richard was granted 1,750 units of Common Stock, increasing direct ownership by 22% to 9,850 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: J Richard Rubino disposed of $6,421 worth of Common Stock (410 units at $15.66), decreasing ownership by 0.12% to 353,937 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: A Thomas Mitro disposed of $11,949 worth of Common Stock (763 units at $15.66), decreasing ownership by 0.87% to 86,709 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: C. Casey Kopczynski disposed of $5,136 worth of Common Stock (328 units at $15.66), decreasing ownership by 0.12% to 264,469 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Jr Vicente Anido disposed of $26,622 worth of Common Stock (1,700 units at $15.66), decreasing ownership by 0.72% to 233,396 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: John Larocca disposed of $24,595 worth of Common Stock (1,542 units at $15.95), decreasing ownership by 4% to 40,437 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: C. Casey Kopczynski exercised 60,651 units of Common Stock at a strike of $0.20 and disposed of $11,897 worth of Common Stock (725 units at $16.41), increasing ownership by 29% to 264,797 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
- SEC Form 4: Jr Vicente Anido disposed of $140,727 worth of Common Stock (7,954 units at $17.69), decreasing ownership by 3% to 235,096 units4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)